Sorento Therapeutics (NASDAQ: SRNE) is causing Wall Street to divide. Some bears are adamant that Sorrento will become a COVID-19 stock that will fade in a few months. Whereas the bulls are aggressively buying up SRNE shares as they believe the biotech has not even come close to its true value. While the overall war […]
Category Archives: US stocks
Seven Eleven buys out Marathon’s Speedway for $21 billion – does YIG see value?
Seven & I Holdings (TYO: 3382) took a bold move on Sunday by agreeing to buy out Speedway gas stations (NYSE: MPC). Despite the dollar tag, investors wonder whether buying up gas stations when the demand for oil is low was smart. Ultimately causing some apprehension as to whether investors should back Seven & I […]
Here’s how much a $10,000 investment in this COVID-19 vaccine company is worth now
The COVID-19 vaccine industry has seen immense investor backing with popular US listed companies such as Moderna, Pfizer and Vaxart multiplying their pre-COVID value upwards of 500%-1,000%. However, Novavax, Inc. (NASDAQ: NVAX) has surpassed it’s rivals in stock value growth, currently priced at $143.10. An investment of $10,000 in NVAX after the initial COVID-19 vaccine […]
Li Xiang jumps 40% on IPO – here is everything you need to know
Li Xang (NASDAQ: LI), an electric vehicle (EV) company, soared 40% on its market debut yesterday. At face value, an investment sounds excellent. Because all EV stocks are rising and it is one day after IPO, so bullish momentum should still be there. However, beneath the water lie sharks such as the ruthless competition of […]
Kandi Technologies climbs 200% on EV expansion into the US – Does YIG see value
The unrealistic gain train keeps on churning as Kandi Technologies (NASDAQ: KNDI) 200% rise is only a day after Kodak’s 300% surge. Kandi is a Chinese Electric Vehicle (EV) maker. Thus it should not be surprising that after their U.S. expansion announcement, we see retail and intuitional investors flock to the stock. Especially as EV […]
Kodak surges 300% on US government COVID-19 deal – does YIG see value in an investment?
Kodak (NYSE: KODK) was suffering from its multi-year downward trend as the iPhone made the Kodak camera look like a dinosaur. However, out of nowhere, the camera company launched itself back on the investing scene after securing a $765 million COVID-19 deal. Kodak will now play a critical role in producing key materials and chemicals […]
Tailored Brands heads for Bankruptcy – Does YIG see value in this Hertz like investment?
Tailored Brands (NYSE: TLRD) bankruptcy is the headline that is spreading wild. While it remains a claim, investors are wondering whether they should invest. Because most investors hear bankruptcy and think of the rental car company Hertz (NASDAQ: HTZ), which made some investors money. Like most insolvency cases there are always competing arguments over the […]
Is Gold ETF GLD a smart investment during COVID – here’s what you need to know
SPDR Gold ETF (ARCX:GLD), like most gold investment vehicles, is gaining significant investor backing during these turbulent times. Economic expectations are changing daily with the virus. Ultimately leaving investors confused as to whether to play gold for the long term, short term, or even not at all. Table of contents 1. How does the Gold […]
Investing in Carnival and Royal Caribbean Cruise lines – Here’s everything you need to know.
Carnival Corp (NYSE: CCL) and Royal Caribbean Cruises (NYSE: RCL) have captivated investor interests as the cruise liners lost 70-75% value as COVID-19 grappled the cruise line industry. Both cruise liners have been on a gradual increase since the initial cliff-fall as speculators continue to buy the corporate giants at discount value. COVID-19 has seriously […]
Boston Beer’s jump 25% on positive Q2 earnings – Does YIG see value?
Boston Beer (NYSE: SAM) set the beverage world alight on Thursday after it beat Wall Street’s Q2 earnings estimate. A beer company exploding during a pandemic might sound unusual. However, the growing light beer industry, and the high demand for alcohol during tough times would say otherwise. The quietness on the vaccine front and the […]